CDK4 and liposarcoma: Fluorescence in situ hybridization for MDM2 amplification can be used to differentiate atypical/highly differentiated liposarcoma and dedifferentiated liposarcoma from PMPF (20), while CDK4 gene amplification helps to differentiate atypical/highly differentiated liposarcoma from PMPF (21).